Induction of cytogenetic adaptive response of somatic and germ cells in vivo and in vitro by low-dose X-irradiation

The cytogenetic adaptive response induced by low-level radiation was studied using human and rabbit lymphocytes in vitro and bone marrow cells and germ cells in vivo. The inductive dose of X-rays was 10 mGy for the in vitro studies at a dose rate of 10 mGy/min, and 2, 10, 50, 75 and 100 mGy for the in vivo studies at a dose rate of 50 mGy/min. The challenging dose was 1.5 Gy X-rays for the in vitro experiments and 0.65 or 0.75 Gy for the in vivo experiments at a dose rate of 0.44 Gy/min. The results reported here, in addition to those that have appeared in the literature, show the following characteristics documented for the first time: (1) 10 mGy could induce the adaptive response in human as well as rabbit lymphocytes irradiated not only in G1, S and G2 phases, but also in the Go state; (2) although the induced adaptive response could only last three cell cycles, it could be revived when the inductive dose was repeated after the third cell cycle; (3) the adaptive response could be induced by low-dose X-rays in somatic cells, both in vitro (lymphocytes) and in vivo (bone marrow cells), and also in germ cells (spermatocytes); (4) the magnitude of the adaptive response induced by whole-body irradiation was found to be dose-dependent--the lower the inductive dose the more the reduction of the frequency of chromatid aberrations following the challenging dose.

Neutralization of enoxaparine-induced bleeding by protamine sulfate

It has been suggested that protamine sulfate is a poor antidote for the bleeding side-effects of low molecular weight heparins (LMWHs) in vivo, since protamine sulfate does not completely neutralize the anti-factor Xa activity of LMWHs in vitro or ex vivo. Therefore, we performed experiments to compare directly the abilities of protamine sulfate to neutralize the anticoagulant activities of the LMWH, enoxaparine, and unfractionated heparin ex vivo, with its ability to neutralize the bleeding side-effects of both compounds in vivo. Bleeding was measured as the amount of blood lost from 5 cuts made in rabbits ears before and after treatment with enoxaparine or unfractionated heparin +/- protamine sulfate. Plasma anti-factor Xa and anti-thrombin activities ex vivo, were measured chromogenically. Doses of 400 and 1,500 anti-factor Xa U/kg of heparin and enoxaparine, respectively, were required to enhance blood loss to the same extent. Protamine sulfate completely neutralized blood loss induced by both compounds, but did not neutralize the anti-factor Xa nor antithrombin activities ex vivo. We conclude that protamine sulfate is an effective antidote for the bleeding side-effects of enoxaparine and unfractionated heparin, despite its inability to completely neutralize their anticoagulant activities.

[PSD-007 luminescence in the diagnosis of exfoliative cells from malignant tumors]

This paper presents the first report in China on the use of luminescence method with hematoporphyrin derivative PSD-007 in the analysis of the exfoliative malignant cells. By this method, pleurorrhea and ascites from 226 suspicious patients were detected. The results showed that its positive rate was 42.23% higher than that of Wright's stain and its positive conformation rate to HE stain could reach as high as 90.2%. Especially, cancer cells could be distinguished from various kinds of non-cancer cells by an objective quantitative analysis of the cellular fluorescent intensity using microfluorophotometer. This new method, being simple, economical and highly specific, is used not only in the qualitative study of the exfoliative tumor cells, but also in the quantitative analysis.